Scholar Rock Holding (SRRK) Free Cash Flow (2017 - 2026)
Scholar Rock Holding's quarterly Free Cash Flow came in at -$82.2 million in Q1 2026, down 4.08% year-on-year from -$85.7 million in Q1 2025, and down 8.79% quarter-over-quarter from -$75.5 million in Q4 2025.
Scholar Rock Holding has reported Free Cash Flow for 10 years, with the latest figure at -$82.2 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 4.08% year-over-year to -$82.2 million; the trailing twelve-month figure through Mar 2026 stood at -$303.9 million (down 32.0% YoY), and the FY2025 full-year result was -$300.6 million, down 49.54% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$82.2 million, down from -$75.5 million in the prior quarter.
- The five-year high for Free Cash Flow was -$25.7 million in Q3 2022, with the low at -$82.2 million in Q1 2026.
- Average Free Cash Flow over 5 years is -$50.8 million, with a median of -$49.2 million recorded in 2024.
- Year-over-year, Free Cash Flow jumped 35.89% in 2022 and sank 62.63% in 2024.
- Tracing SRRK's Free Cash Flow over 5 years: stood at -$29.9 million in 2022, then slipped by 25.08% to -$37.3 million in 2023, then sank by 32.63% to -$49.5 million in 2024, then slumped by 52.47% to -$75.5 million in 2025, then fell by 8.79% to -$82.2 million in 2026.
- The last three Free Cash Flow figures came in at -$82.2 million (Q1 2026), -$75.5 million (Q4 2025), and -$69.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | -82.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.17 Mn |
| Mar 31, 2026 | -82.17 Mn |
| Dec 31, 2025 | -75.53 Mn |
| Dec 31, 2025 | -75.53 Mn |
| Sep 30, 2025 | -69.01 Mn |
| Sep 30, 2025 | -69.01 Mn |
| Jun 30, 2025 | -77.16 Mn |
| Jun 30, 2025 | -77.16 Mn |
| Mar 31, 2025 | -78.95 Mn |
| Mar 31, 2025 | -78.95 Mn |
| Dec 31, 2024 | -49.54 Mn |
| Dec 31, 2024 | -49.54 Mn |
| Sep 30, 2024 | -52.49 Mn |
| Sep 30, 2024 | -52.49 Mn |
| Jun 30, 2024 | -49.23 Mn |
| Jun 30, 2024 | -49.23 Mn |
| Mar 31, 2024 | -49.80 Mn |
| Mar 31, 2024 | -49.80 Mn |
| Dec 31, 2023 | -37.35 Mn |
| Dec 31, 2023 | -37.35 Mn |
| Sep 30, 2023 | -32.27 Mn |
| Sep 30, 2023 | -32.27 Mn |
| Jun 30, 2023 | -32.59 Mn |
| Jun 30, 2023 | -32.59 Mn |
| Mar 31, 2023 | -43.08 Mn |
| Mar 31, 2023 | -43.08 Mn |
| Dec 31, 2022 | -29.86 Mn |
| Dec 31, 2022 | -29.86 Mn |
| Sep 30, 2022 | -25.68 Mn |
| Sep 30, 2022 | -25.68 Mn |
| Jun 30, 2022 | -35.25 Mn |
| Jun 30, 2022 | -35.25 Mn |
| Mar 31, 2022 | -42.98 Mn |
| Mar 31, 2022 | -42.98 Mn |
| Dec 31, 2021 | -33.00 Mn |
| Dec 31, 2021 | -33.00 Mn |
| Sep 30, 2021 | -40.05 Mn |
| Sep 30, 2021 | -40.05 Mn |
| Jun 30, 2021 | -30.14 Mn |
| Jun 30, 2021 | -30.14 Mn |
| Mar 31, 2021 | -28.86 Mn |
| Mar 31, 2021 | -28.86 Mn |
| Dec 31, 2020 | -21.66 Mn |
| Dec 31, 2020 | -21.66 Mn |
| Sep 30, 2020 | -25.23 Mn |
| Sep 30, 2020 | -25.23 Mn |
| Jun 30, 2020 | -20.10 Mn |
| Jun 30, 2020 | -20.10 Mn |
| Mar 31, 2020 | 2.63 Mn |
| Mar 31, 2020 | 2.63 Mn |
| Dec 31, 2019 | -17.54 Mn |
| Dec 31, 2019 | -17.54 Mn |
| Sep 30, 2019 | -16.73 Mn |
| Sep 30, 2019 | -16.73 Mn |
| Jun 30, 2019 | -15.95 Mn |
| Jun 30, 2019 | -15.95 Mn |
| Mar 31, 2019 | -16.01 Mn |
| Mar 31, 2019 | -16.01 Mn |
| Dec 31, 2018 | 54.39 Mn |
| Dec 31, 2018 | 54.39 Mn |
| Sep 30, 2018 | -9.61 Mn |
| Sep 30, 2018 | -9.61 Mn |
| Jun 30, 2018 | -11.81 Mn |
| Jun 30, 2018 | -11.81 Mn |
| Mar 31, 2018 | -9.90 Mn |
| Mar 31, 2018 | -9.90 Mn |
| Dec 31, 2017 | -6.36 Mn |
| Dec 31, 2017 | -6.36 Mn |
| Sep 30, 2017 | -5.60 Mn |
| Sep 30, 2017 | -5.60 Mn |